Ion pumps establish homeostasis across the membranes of living cells. Hearing is a mechanotransduction event that takes place in a closed compartment containing a fluid high in K+ concentrations. In Drosophila melanogaster, this closed compartment is formed by a scolopale cell that wraps around the dendrite of sensory neurons. The receptor lymph is maintained by the scolopale cell. The lumenal membrane of the scolopale cell is the wall of the compartment containing the receptor lymph, the scolopale space. The ablumenal membrane of the scolopale cell creates the border of the scolopidium. The Na/K pump is located on the ablumenal membrane of the scolopale cell, bringing K+ into the scolopale cell cytoplasm and extruding K electrogenically (Roy et al, 2013). We explored other primary and secondary ion pumps that are involved in creating a K+-rich lumen in the Malpighian tubule (Day et al, 2008; Rodan et al, 2012). We used RNAi technology to knockdown one gene at a time and electrophysiology to measure a sound evoked potential (SEP) that reflects the fly’s ability to hear. We found that knocking down V-ATPase, a proton pump, subunits involved in proton extrusion significantly reduces the SEP of knockdown flies. The involvement of cation chloride cotransporters (CCCs) and cation proton antiporter (CPAs), both secondary ion pumps that use the gradients created by the Na/K pump and V-ATPase respectively to pump other ions up their gradient, is less clear. We found that knocking down Nhe3, a CPA, significantly reduced the SEP when knocked down in the scolopale cell, suggesting it as a partner to the V-ATPase. Knocking down CG31547, a CCC, statistically increased the SEP, possibly a type1 statistical error.

<p>Organophosphorus pesticides (OPs) are neuroactive compounds that can affect the development of the nervous system and behavior. Using zebrafish, we compared the effectiveness of three different OPs, chlorpyrifos (CPF), diazinon (DZN) and parathion (PA) on survival, AChE inhibition and larval motility. We conclude that at equimolar concentrations CPF is the most effective OP of the three tested. 300nM CPF inhibited AChE when measured at 5 days post fertilization (dpf) by 80%, which correlated to a 35% decrease in larval motility when measured at 6 dpf. </p><p>We isolated the cDNA of <italic>zfkcc2</italic>, which encodes for an important cation-chloride cotransporter responsible for establishing a chloride gradient that allows for the neurotransmitter GABA to become inhibitory for a subset of neurons. By isolating the cDNA of <italic>zfkcc2</italic>, we were able to characterize its expression pattern up to 4 dpf. Using qRT-PCR, we showed that the expression of <italic>zfkcc2</italic> rises from 2 to 96 hours post fertilization (hpf). The expression of <italic>zfkcc2</italic> is found at 1 dpf in the forebrain, midbrain and hindbrain in a distinct pattern. By 3 dpf, zfkcc2 expression is found throughout most of the developing zebrafish brain. We were then able to characterize the expression pattern of zfnkcc1, which encodes for a cation-chloride cotransporter that works opposite to <italic>zfkcc2</italic> and establishes a chloride gradient allowing GABA to be excitatory during development. Expression of <italic>zfnkcc1</italic> is found at 1 dpf throughout most of the developing zebrafish head including in some non-neural tissue, but appears concentrated to the otic vesicle at 3 dpf. Using double in situ hybridization, we investigated the nature of the developmental switch from zfnkcc1 to zfkcc2 by looking at regions where there was an interaction between both genes' expression patterns in the developing zebrafish nervous system. </p><p>We preliminarily examined how affecting nicotinic signaling with exposures to nicotinic agonists/antagonists can affect the expression of <italic>zfnkcc2</italic> and <italic>zfkcc2</italic>. While there were no apparent changes in the expression pattern from any of the exposures at 2 dpf, we found that by 3 dpf nicotine and CPF exposures resulted in an incomplete expression pattern for <italic>zfkcc2</italic> that seemed to be delayed. However, the expression of <italic>zfnkcc1</italic> at the otic vesicle was unaffected by exposure. </p><p>Our results suggest that disrupting nicotinic signaling during development can affect the expression of an important cation-chloride cotransporter, <italic>zfkcc2</italic>, that plays a major role in establishing the necessary chloride gradient for the proper functioning of GABA during development. Future studies should focus on investigating the nature of the developmental switch between <italic>zfnkcc1</italic> and <italic>zfkcc2</italic> to see if the possibility of their regulation being coupled is a target for exposures.</p> / Dissertation

L’inhibition est nécessaire à la génération d’outputs coordonnés entre muscles antagonistes lors de la locomotion. Une baisse de la concentration neuronale en ions chlorure au cours du développement des mammifères conduit à l’émergence de l’inhibition. Cette baisse repose sur l’équilibre entre deux cotransporteurs cation-chlorure, KCC2 et NKCC1. KCC2 expulse Cl- de la cellule alors que NKCC1 pompe Cl- dans la cellule. L’opossum Monodelphis domestica naît dans un état très immature. Le seul comportement locomoteur qu’il présente à la naissance consiste en des mouvements rythmiques et alternés des membres antérieurs pour grimper le long du ventre de la mère vers une tétine. Les membres postérieurs sont des bourgeons immobiles dont le développement est en grande partie postnatal. Pour cette raison, cette espèce constitue un modèle idéal pour l’étude du développement locomoteur. Afin d’étudier les mécanismes conduisant à l’émergence de l’inhibition durant le développement moteur, nous avons décrit l’expression développementale de KCC2 et NKCC1 chez l’opossum postnatal par immunohistochimie au niveau des renflements spinaux. Les motoneurones et afférences primaires ont été identifiés en utilisant un marquage rétrograde au TRDA. Le marquage pour KCC2 et NKCC1 est détecté dans la moelle épinière ventrale dans la matière grise et blanche présomptive dès la naissance, ce qui suggère que l’inhibition serait déjà mise en place avant la naissance, permettant subséquemment l’alternance des membres antérieurs observée chez les nouveau-nés. L’expression développementale de KCC2 et NKCC1 suit des gradients ventrodorsal et médiolatéral, tels qu’observés chez les rongeurs (rats et souris). Le patron mature d’expression de ces cotransporteurs est observé aux alentours de la 5ème semaine postnatale lorsque la locomotion de l’opossum est mature. Enfin, entre la naissance et P5, les dendrites exprimant KCC2 au niveau de la corne dorsale sont retrouvées en apposition aux afférences primaires ce qui suggère un rôle de KCC2 dans la formation des circuits sensori-moteurs. / Inhibition is necessary to generate coordinated outputs between antagonistic muscles during locomotion. Inhibition is set by a lowering in neuronal chloride concentration during mammalian development. This lowering relies on the proper balance between two cation-chloride cotransporters, KCC2 and NKCC1. KCC2 extrudes Cl- out of the cell while NKCC1 pumps Cl- into the cell. The opossum Monodelphis domestica is born at a very rudimentary stage of development. Newborn opossums show rhythmic and alternate movements of the forelimbs as they crawl on the mother's belly to a nipple. The hindlimbs are immobile paddle-shaped buds and their development is mostly postnatal. Thus, this species is an ideal model to study motor development. In order to investigate the mechanisms involved in the appearance of inhibition during motor development, we described the developmental expression of KCC2 and NKCC1 on postnatal opossums using immunohistochemistry in the spinal cord enlargements. Motoneurons and primary sensory afferents were identified using retrograde labeling with TRDA. Immunolabeling for both KCC2 and NKCC1 is detected in the ventral spinal cord in the presumptive grey and white matter from birth on, suggesting that the development of inhibition begins before birth, enabling the alternate movements exhibited by the newborns. The developmental expression of KCC2 and NKCC1 follows ventrodorsal and mediolateral gradients, similar to those demonstrated in rodents (rats and mice). The mature pattern for both cotransporters is observed around the 5th week at a time when opossums demonstrate mature patterns of locomotion. Between birth and P5, dendrites expressing KCC2 in the dorsal horn superimpose on the primary afferents, suggesting a role for KCC2 in the establishment of sensorimotor circuits.

L’inhibition est nécessaire à la génération d’outputs coordonnés entre muscles antagonistes lors de la locomotion. Une baisse de la concentration neuronale en ions chlorure au cours du développement des mammifères conduit à l’émergence de l’inhibition. Cette baisse repose sur l’équilibre entre deux cotransporteurs cation-chlorure, KCC2 et NKCC1. KCC2 expulse Cl- de la cellule alors que NKCC1 pompe Cl- dans la cellule. L’opossum Monodelphis domestica naît dans un état très immature. Le seul comportement locomoteur qu’il présente à la naissance consiste en des mouvements rythmiques et alternés des membres antérieurs pour grimper le long du ventre de la mère vers une tétine. Les membres postérieurs sont des bourgeons immobiles dont le développement est en grande partie postnatal. Pour cette raison, cette espèce constitue un modèle idéal pour l’étude du développement locomoteur. Afin d’étudier les mécanismes conduisant à l’émergence de l’inhibition durant le développement moteur, nous avons décrit l’expression développementale de KCC2 et NKCC1 chez l’opossum postnatal par immunohistochimie au niveau des renflements spinaux. Les motoneurones et afférences primaires ont été identifiés en utilisant un marquage rétrograde au TRDA. Le marquage pour KCC2 et NKCC1 est détecté dans la moelle épinière ventrale dans la matière grise et blanche présomptive dès la naissance, ce qui suggère que l’inhibition serait déjà mise en place avant la naissance, permettant subséquemment l’alternance des membres antérieurs observée chez les nouveau-nés. L’expression développementale de KCC2 et NKCC1 suit des gradients ventrodorsal et médiolatéral, tels qu’observés chez les rongeurs (rats et souris). Le patron mature d’expression de ces cotransporteurs est observé aux alentours de la 5ème semaine postnatale lorsque la locomotion de l’opossum est mature. Enfin, entre la naissance et P5, les dendrites exprimant KCC2 au niveau de la corne dorsale sont retrouvées en apposition aux afférences primaires ce qui suggère un rôle de KCC2 dans la formation des circuits sensori-moteurs. / Inhibition is necessary to generate coordinated outputs between antagonistic muscles during locomotion. Inhibition is set by a lowering in neuronal chloride concentration during mammalian development. This lowering relies on the proper balance between two cation-chloride cotransporters, KCC2 and NKCC1. KCC2 extrudes Cl- out of the cell while NKCC1 pumps Cl- into the cell. The opossum Monodelphis domestica is born at a very rudimentary stage of development. Newborn opossums show rhythmic and alternate movements of the forelimbs as they crawl on the mother's belly to a nipple. The hindlimbs are immobile paddle-shaped buds and their development is mostly postnatal. Thus, this species is an ideal model to study motor development. In order to investigate the mechanisms involved in the appearance of inhibition during motor development, we described the developmental expression of KCC2 and NKCC1 on postnatal opossums using immunohistochemistry in the spinal cord enlargements. Motoneurons and primary sensory afferents were identified using retrograde labeling with TRDA. Immunolabeling for both KCC2 and NKCC1 is detected in the ventral spinal cord in the presumptive grey and white matter from birth on, suggesting that the development of inhibition begins before birth, enabling the alternate movements exhibited by the newborns. The developmental expression of KCC2 and NKCC1 follows ventrodorsal and mediolateral gradients, similar to those demonstrated in rodents (rats and mice). The mature pattern for both cotransporters is observed around the 5th week at a time when opossums demonstrate mature patterns of locomotion. Between birth and P5, dendrites expressing KCC2 in the dorsal horn superimpose on the primary afferents, suggesting a role for KCC2 in the establishment of sensorimotor circuits.

Les glioblastomes (GBM) sont les formes les plus agressives de tumeurs gliales avec une survie médiane des patients traités n’excédant pas 2 ans. Ce mauvais pronostic est dû, entre autres, à l’hétérogénéité de ces tumeurs avec la présence de cellules souches cancéreuses (CSCs) en prolifération ou quiescentes, particulièrement résistantes aux traitements conventionnels. Cibler ces cellules au sein du microenvironment tumoral hypoxique et acides fait donc partie des thérapies d’avenir des GBMs. Le laxatif bisacodyl a été identifié par criblage de la chimiothèque Prestwick comme un composé induisant la mort par nécrose des CSCs de glioblastome (GSCs en prolifération et en quiescence), uniquement dans des conditions de faible acidité retrouvées également au sein des tumeurs. Une activité antitumorale in vivo a également été démontrée pour ce composé. Cette thèse présente l’identification du mode d’action du bisacodyl dans les GSCs. Celui-ci implique la serine/thréonine kinase WNK1 et ses partenaires, les kinases Akt et SGK1 et des co-transporteurs Na+/HCO3- NBC. Nos résultats ont également révélé un rôle de WNK1 dans la physiopathologie des GSCs. / Glioblastoma (GBM), the most aggressive glial tumor, is currently incurable with a very short-term patient survival (< 2 years). The heterogeneity of GBM and the presence of highly resistant proliferating and quiescent cancer stem-like cells (CSCs), is largely responsible for poor prognosis in this disease. Thus, new approaches targeting glioblastoma CSCs (GSCs), within the acidic/hypoxic tumor microenvironment, are promising strategies for treating GBM. The laxative bisacodyl was identified in a high throughput screening of the Prestwick chemical library as a compound inducing necrotic cell death in proliferating and quiescent GSCs only in acidic microenvironments similar to those found in tumors. Bisacodyl was further shown to induce tumor shrinking and to increase survival in in vivo GBM models. In this thesis work, we identify bisacodyl’s mechanism of action in GSCs. This mechanism involves the serine/threonine kinase WNK1 and its signaling partners including protein kinases Akt and SGK1 and NBC Na+/HCO3- cotransporters. Our data also highlight a previously unknown role of WNK1 in GSC physiopathology.

<p>The regulation of serum phosphate (Pi) concentrations is a complex process and our current models are far from complete. Due to major advancements in biotechnology and the development of more powerful research tools, recent advances in the field of genetics has led to the identification of several candidates for the long sought-after phosphatonin(s), or Pi regulating hormones. One of these candidates is fibroblast growth factor 23 (FGF-23) and this thesis is based upon studies of the role of FGF-23 in Pi homeostasis. We demonstrate that FGF-23 is a secreted protein which is highly expressed in tumors giving rise to oncogenic hypophosphatemic osteomalacia (OOM). Furthermore, we have developed a two-site enzyme-linked immunosorbent assay for the detection of circulating FGF-23 and established that FGF-23 is present in the circulation of healthy individuals. Also, FGF-23 serum levels are elevated in patients with disturbances in Pi homeostasis such as OOM, X-linked hypophosphatemic rickets (XLH) and chronic kidney disease and are likely to play an important role in the pathogenesis of these disorders. A transgenic mouse model that express human FGF-23 under the control of the α1(I) collagen promoter exhibit similar clinical and biochemical characteristics as do patients with OOM, XLH and autosomal dominant hypophosphatemic rickets indicating that FGF-23 is an important determinant of Pi homeostasis, vitamin D metabolism and bone mineralization.</p>

The regulation of serum phosphate (Pi) concentrations is a complex process and our current models are far from complete. Due to major advancements in biotechnology and the development of more powerful research tools, recent advances in the field of genetics has led to the identification of several candidates for the long sought-after phosphatonin(s), or Pi regulating hormones. One of these candidates is fibroblast growth factor 23 (FGF-23) and this thesis is based upon studies of the role of FGF-23 in Pi homeostasis. We demonstrate that FGF-23 is a secreted protein which is highly expressed in tumors giving rise to oncogenic hypophosphatemic osteomalacia (OOM). Furthermore, we have developed a two-site enzyme-linked immunosorbent assay for the detection of circulating FGF-23 and established that FGF-23 is present in the circulation of healthy individuals. Also, FGF-23 serum levels are elevated in patients with disturbances in Pi homeostasis such as OOM, X-linked hypophosphatemic rickets (XLH) and chronic kidney disease and are likely to play an important role in the pathogenesis of these disorders. A transgenic mouse model that express human FGF-23 under the control of the α1(I) collagen promoter exhibit similar clinical and biochemical characteristics as do patients with OOM, XLH and autosomal dominant hypophosphatemic rickets indicating that FGF-23 is an important determinant of Pi homeostasis, vitamin D metabolism and bone mineralization.